Invention Grant
- Patent Title: RNA molecules encoding cytokine fusion proteins and methods of use thereof
-
Application No.: US15780599Application Date: 2016-12-16
-
Publication No.: US10669322B2Publication Date: 2020-06-02
- Inventor: Ugur Sahin , Friederike Gieseke , Sebastian Kreiter , Mustafa Diken
- Applicant: BIONTECH RNA PHARMACEUTICALS GMBH , TRON TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GGMBH
- Applicant Address: DE Mainz DE Mainz
- Assignee: BIONTECH RNA PHARMACEUTICALS GMBH,TRON—TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GGMBH
- Current Assignee: BIONTECH RNA PHARMACEUTICALS GMBH,TRON—TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GGMBH
- Current Assignee Address: DE Mainz DE Mainz
- Agency: Sheppard Mullin Richter & Hampton LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@328fddd7
- International Application: PCT/EP2016/081401 WO 20161216
- International Announcement: WO2017/103088 WO 20170622
- Main IPC: C07K14/54
- IPC: C07K14/54 ; C07K14/705 ; C12N15/62 ; C07K14/525 ; A61K38/00
Abstract:
The present invention relates to cytokine fusion proteins and to nucleic acid molecules encoding such cytokine fusion proteins. The present invention further relates to cells, non-human organisms, pharmaceutical compositions and kits comprising the cytokine fusion proteins or the nucleic acid molecules encoding them, as well as to their use as medicaments.
Public/Granted literature
- US20180371042A1 NOVEL CYTOKINE FUSION PROTEINS Public/Granted day:2018-12-27
Information query
